Revvity’s shares (currently trading at $111) have posted a disappointing 8.5% loss, well below the S&P 500’s 5.1% gain. This ...

Discover how Revvity's strategic acquisitions and financial improvements position it for long-term growth in cell and gene ...

Revvity (RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce ...

Experienced finance chief William J. Kullback has joined the board of Cambridge biotech business Nuclera as a Non Executive ...

Bretton Capital Management, an investment management company, released “Bretton Fund” fourth quarter 2024 investor letter. A ...

PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery ...

Our robotic platforms provide high-throughput sample handling. by robots. KI Biobank automation includes platforms provided by Roche, Tecan, Hamilton, Qiagen and Revvity (PerkinElmer). The automated ...

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total ...